Stock listing

Dusseldorf:A5I AtriCure, Inc. Aktie

German listing (Dusseldorf) of AtriCure, Inc. · home listing NASDAQ:ATRC

Follow AtriCure, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:ATRC

$55.39 USD -0.06 (-0.1%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ATRC

Past year +66.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$54.03 – $56.14 USDNov 20, 2026
Volume
813,080 sharesNov 20, 2026
Market cap
$2.82B USDAt the close on Nov 20, 2026 · price × 50.92M shares outstanding
52-week range
$25.36 – $66.02 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$58.43M USDMedian day 850,600 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
AtriCure, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ATRC · Home$55.39 USD-0.06 (-0.1%)813,080$54.03$56.14$54.03$55.45Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ATRC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$55.39-0.06-0.1%$54.03$56.14$54.03813,080
$55.45+0.43+0.8%$54.10$56.47$54.09595,164
$55.02-0.29-0.5%$55.32$55.98$53.88611,228
$55.31-1.53-2.7%$57.00$57.18$55.02560,829
$56.84+0.86+1.5%$56.11$57.28$55.81558,768
$55.98-1.55-2.7%$58.01$58.24$55.76462,388
$57.53+1.27+2.3%$56.42$57.68$56.03644,939
$56.26-1.52-2.6%$57.10$57.49$54.74838,143
$57.78-0.76-1.3%$58.62$59.85$57.181,026,136
$58.54-2.74-4.5%$60.00$61.11$58.35613,513
$61.28-4.25-6.5%$65.00$66.00$60.58978,420
$65.53+5.12+8.5%$58.06$66.02$58.001,335,542
$60.41+0.53+0.9%$59.45$61.54$59.101,591,666
$59.88-1.37-2.2%$61.70$62.33$59.141,115,758
$61.25-1.23-2.0%$62.41$62.41$59.70961,279
$62.48+1.06+1.7%$61.71$62.86$61.69701,155
$61.42-0.09-0.1%$61.37$63.00$61.06647,548
$61.51+0.43+0.7%$60.86$61.78$60.08783,123
$61.08+2.11+3.6%$59.35$61.17$58.85815,923
$58.97-0.33-0.6%$58.94$59.56$58.53497,089
$59.30+1.63+2.8%$57.76$59.54$57.76498,177
$57.670.000.0%$57.73$59.29$57.13566,328
$57.67+2.14+3.9%$55.64$58.20$55.64446,379
$55.53-0.54-1.0%$55.75$56.58$55.16607,217
$56.07-1.71-3.0%$57.98$58.31$55.90648,300
$57.78+0.48+0.8%$57.83$58.44$56.27850,900
$57.30+0.43+0.8%$56.13$57.89$55.84799,300
$56.87-0.41-0.7%$57.60$57.98$56.39596,100
$57.28+1.47+2.6%$56.29$57.35$55.67645,600
$55.81+2.97+5.6%$53.14$55.89$52.44712,500
$52.84-0.47-0.9%$53.07$53.46$51.63595,600
$53.31-0.37-0.7%$53.35$54.88$52.98753,500
$53.68-2.69-4.8%$55.97$56.58$53.43863,700
$56.37+1.23+2.2%$54.14$56.60$53.861,095,500
$55.14+1.55+2.9%$52.51$55.25$52.001,615,500
$53.59-2.61-4.6%$56.52$56.99$52.601,970,900
$56.20-1.85-3.2%$58.01$58.60$56.151,111,200
$58.05-0.36-0.6%$58.58$59.05$56.59876,300
$58.41+0.03+0.1%$57.56$58.49$56.901,161,800
$58.38-2.39-3.9%$60.85$61.32$57.891,591,200
$60.77+0.81+1.4%$59.63$61.70$59.131,304,900
$59.96+1.13+1.9%$58.92$61.48$58.721,206,200
$58.83+0.51+0.9%$58.62$59.69$57.94871,600
$58.32+0.22+0.4%$58.23$59.11$56.971,039,700
$58.10-1.02-1.7%$58.51$59.88$57.988,670,300
$59.12+1.98+3.5%$57.96$59.59$57.311,539,600
$57.14+0.92+1.6%$55.66$57.25$55.661,216,900
$56.22+0.43+0.8%$56.00$56.78$54.651,432,300
$55.79+1.25+2.3%$54.84$56.02$54.811,154,700
$54.54+1.58+3.0%$53.53$55.16$53.521,098,900
$52.96-0.07-0.1%$52.31$53.66$51.86961,900
$53.03-0.70-1.3%$53.16$53.71$51.971,659,500
$53.73+2.21+4.3%$54.31$55.72$51.741,880,200
$51.52-0.94-1.8%$52.03$52.53$51.03714,100
$52.46-0.13-0.2%$52.88$53.50$51.191,169,100
$52.59+3.67+7.5%$49.76$52.69$49.541,262,600
$48.92+0.57+1.2%$48.43$49.25$47.54717,600
$48.35-0.19-0.4%$48.23$48.85$46.61529,100
$48.54-0.73-1.5%$49.32$49.98$48.35390,600
$49.27+1.10+2.3%$48.22$49.45$47.82766,400
$48.17-0.51-1.0%$48.02$48.55$47.06859,700
$48.68-0.60-1.2%$49.01$49.41$48.11966,500
$49.28+0.30+0.6%$49.58$49.88$48.53438,900
$48.98+1.49+3.1%$47.50$49.20$46.99421,100
$47.49-0.12-0.3%$47.28$48.46$46.70850,600
Ticker
Dusseldorf:A5I
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Dusseldorf
Currency
EUR

What changed lately

Latest news

All AtriCure, Inc. news

AtriCure, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
17 in the last 12 months · 142 in all · newest Nov 17, 2026 · oldest 2019
Calls
31 calls with a replay · 31 with a transcript · latest Nov 3, 2026
Decks
45 decks · latest July 2026

Where AtriCure, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ATRC · Home listingNASDAQUnited StatesUSD
Frankfurt:A5IFrankfurtGermanyEUR
Tradegate:A5ITradegateGermanyEUR
BOATS:ATRCBOATSUnited StatesUSD
Dusseldorf:A5I · This pageDusseldorfGermanyEUR
Hamburg:A5IHamburgGermanyEUR

Valuation

P/E 190× against a median of 25.4×: the highest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$2.69B USD
P/E
190×
EV/sales
4.6×
EV/EBITDA
75.2×
Price/book
5.3×
Gross margin
76.7%
Operating margin
2.9%
Net margin
2.5%
Debt to equity
0.1×
Beta vs S&P 500
0.58

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
AtriCure, Inc. · NASDAQ:ATRCUS$2.82BUS$2.69B190×4.6×75.2×5.3×2.5%0.1×0.58
Zhende Medical Co., Ltd. Class A · SSE:603301US$3.23BUS$3.13B73.1×4.5×n/a3.8×6.3%0.1×n/a
Lepu Medical Technology (Beijing) Co., Ltd. Class A · SZSE:300003US$3.10BUS$3.03B31.4×3.3×n/a1.3×10.7%0.2×n/a
Carl Zeiss Meditec AG · XETR:AFXUS$3.06BUS$3.06B23.9×1.1×n/a1.3×4.4%0.0×n/a
Imricor Medical Systems, Inc. · ASX:IMRUS$2.99BUS$2.96Bn/a9,790×n/a103×n/a1.2×n/a
TransMedics Group, Inc. · NASDAQ:TMDXUS$2.96BUS$2.52B20.5×3.5×19.8×5.4×19.9%0.1×1.31
Ambu A/S Class B · OMXCOP:AMBU_BUS$2.92BUS$2.92B30.9×3.1×15.9×3.2×9.9%0.1×n/a
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H · HKEX:2252US$2.77BUS$2.74Bn/a33.1×n/a44.9×−45.3%1.0×n/a
Ottobock SE & Co. KGaA · XETR:OBCKUS$2.65BUS$3.54B26.8×1.9×8.0×6.1×5.4%2.3×n/a
Winner Medical Co. Ltd. Class A · SZSE:300888US$2.47BUS$1.75B21.2×1.0×n/a1.4×6.9%0.0×n/a
Medacta Group SA · SIX:MOVEUS$2.40BUS$2.72B22.8×3.6×13.0×4.5×14.0%0.7×n/a
Median of the othersUS$2.94BUS$2.94B25.4×3.4×14.5×4.1×6.9%0.2×1.31

Forecasts

4 strong buy · 3 buy · 3 hold · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
64.89 USD · Analysts' mean
EPS, year to Dec 2026
0.43 · 7 analysts
Revenue, year to Dec 2026
608.3M · 10 analysts

Team and board

Officers

OfficerRole
Michael H. CarrelPresident, Chief Executive Officer and Director
Angela L. WirickChief Financial Officer
Douglas J. SeithChief Operating Officer
Karl DahlquistChief Legal Officer
Justin NozneskyChief Marketing and Strategy Officer
Salvatore PriviteraChief Technical Officer
Vinayak DoraiswamyChief Scientific Officer

Board

DirectorRole
B. Kristine JohnsonDirector
Deborah H. TelmanDirector
Karen N. PrangeDirector
Maggie S. YuenDirector
Michael H. CarrelPresident, Chief Executive Officer and Director
Regina E. GrovesDirector
Robert S. WhiteDirector
Shlomi NachmanDirector
Sven A. WehrweinDirector

Events

Calls

CallWhenStatus
AtriCure (NASDAQ:ATRC) Q3 2026 Earnings CallTue, Nov 03, 2026 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q2 2026 Earnings CallThu, Jul 23, 2026 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q1 2026 Earnings CallTue, May 05, 2026 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q4 2025 Earnings CallTue, Feb 17, 2026 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q3 2025 Earnings CallWed, Oct 29, 2025 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q2 2025 Earnings CallTue, Jul 29, 2025 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q1 2025 Earnings CallTue, Apr 29, 2025 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q4 2024 Earnings CallWed, Feb 12, 2025 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q3 2024 Earnings CallTue, Oct 29, 2024 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q2 2024 Earnings CallTue, Jul 30, 2024 · 4:30 PM ETReplay
All 31 calls
CallWhenStatus
AtriCure (NASDAQ:ATRC) Q1 2024 Earnings CallWed, May 01, 2024 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q3 2023 Earnings CallWed, Nov 01, 2023 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q2 2023 Earnings CallTue, Jul 25, 2023 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q1 2023 Earnings CallTue, May 02, 2023 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q4 2022 Earnings CallTue, Feb 21, 2023 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q3 2022 Earnings CallTue, Nov 01, 2022 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q2 2022 Earnings CallTue, Aug 02, 2022 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q1 2022 Earnings CallTue, May 03, 2022 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q4 2021 Earnings CallTue, Feb 15, 2022 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q3 2021 Earnings CallWed, Nov 03, 2021 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q2 2021 Earnings CallWed, Aug 04, 2021 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q1 2021 Earnings CallTue, Apr 27, 2021 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q4 2020 Earnings CallTue, Feb 23, 2021 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q3 2020 Earnings CallThu, Nov 05, 2020 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q2 2020 Earnings CallTue, Jul 28, 2020 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q1 2020 Earnings CallWed, Apr 29, 2020 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q4 2019 Earnings CallTue, Feb 18, 2020 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q3 2019 Earnings CallWed, Oct 30, 2019 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q2 2019 Earnings CallTue, Jul 30, 2019 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q1 2019 Earnings CallThu, Apr 25, 2019 · 4:30 PM ETReplay
AtriCure (NASDAQ:ATRC) Q4 2018 Earnings CallSat, Mar 02, 2019 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 3, 2026 · After close+8.5%
Q2 2026Jul 23, 2026 · After close+6.2%
Q1 2026May 5, 2026 · After close−4.7%
Q4 2025Feb 17, 2026 · After close−2.1%
Q3 2025Oct 29, 2025 · After close−3.8%
Q2 2025Jul 29, 2025 · After close+10.7%
Q1 2025Apr 29, 2025 · After close−13.7%
Q4 2024Feb 13, 2025 · Before open−6.5%
Q3 2024Oct 29, 2024 · After close+18.4%
Q2 2024Jul 30, 2024 · After close−1.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 1, 2024 · After close−10.3%
Q4 2023Feb 15, 2024 · After close−4.4%
Q3 2023Nov 1, 2023 · After close+4.5%
Q2 2023Jul 25, 2023 · After close+8.5%
Q1 2023May 2, 2023 · After close+10.0%
Q4 2022Feb 21, 2023 · After close+8.3%
Q3 2022Nov 1, 2022 · After close−6.0%
Q2 2022Aug 2, 2022 · After close−0.6%
Q1 2022May 3, 2022 · After close−2.4%
Q4 2021Feb 15, 2022 · After close+3.7%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings24 slidesJuly 2026
Investor Presentation (May 2026)Investor deck25 slidesMay 2026
J.P. Morgan 44th Annual Healthcare Conference (January 2026)Conference25 slidesJanuary 2026
Fact Sheet (December 2025)Fact sheet2 slidesDecember 2025
Q3 2025 Earnings PresentationEarnings22 slidesOctober 2025
Investor Presentation (August 2025)Investor deck11 slidesAugust 2025
Technical Presentation (August 2025)Technical21 slidesAugust 2025
Investor Presentation (July 2025)Investor deck22 slidesJuly 2025
Q1 2025 Earnings PresentationEarnings22 slidesApr 29, 2025
Investor Day (March 2025)Investor day30 slidesMarch 2025
All 45 decks
DeckKindSlidesDate
Q4 2024 Earnings PresentationEarnings22 slidesFeb 12, 2025
J.P. Morgan Healthcare Conference 2025Conference21 slidesJanuary 2025
Q3 2024 Earnings PresentationEarnings15 slidesOct 29, 2024
Fact Sheet (September 2024)Fact sheet2 slidesSeptember 2024
Q2 2024 Earnings PresentationEarnings15 slidesJul 30, 2024
Q1 2024 Earnings PresentationEarnings17 slidesMay 1, 2024
Q3 2023 Earnings PresentationEarnings28 slidesNov 1, 2023
Q2 2023 Earnings PresentationEarnings28 slidesJul 25, 2023
Investor Presentation (May 2023)Investor deck28 slidesMay 2023
Investor Presentation (February 2023)Investor deck28 slidesFebruary 2023
J.P. Morgan Healthcare Conference 2023Conference18 slidesJan 9, 2023
Investor Presentation (November 2022)Investor deck34 slidesNovember 2022
Investor Presentation (September 2022)Investor deck7 slidesSeptember 2022
Investor Presentation (August 2022)Investor deck33 slidesAugust 2022
Investor Presentation (May 2022)Investor deck33 slidesMay 2022
Investor Presentation (January 2022)Investor deck28 slidesJan 10, 2022
Fact Sheet (September 2021)Fact sheet2 slidesSeptember 2021
Investor Presentation (August 2021)Investor deck30 slidesAug 4, 2021
Investor Presentation (January 2021)Investor deck26 slidesJan 11, 2021
Investor Presentation (2021)Investor deck30 slides2021
Investor Presentation (November 2020)Investor deck23 slidesNov 5, 2020
Fact Sheet (September 2020)Fact sheet2 slidesSeptember 2020
Investor Presentation (April 2020)Investor deck25 slidesApr 29, 2020
Investor Presentation (January 2020)Investor deck25 slidesJan 13, 2020
Merger or Acquisition (August 2019)Merger or acquisition25 slidesAug 12, 2019
Investor Presentation (January 2019)Investor deck41 slidesJan 7, 2019
Investor Presentation (January 2018)Investor deck35 slidesJan 8, 2018
Investor Presentation (August 2017)Investor deck36 slidesAug 21, 2017
Investor Presentation (January 2017)Investor deck42 slidesJan 9, 2017
Investor Presentation (January 2016)Investor deck37 slidesJan 11, 2016
Investor Presentation (January 2015)Investor deck31 slidesJan 12, 2015
Investor Presentation (January 2013)Investor deck22 slidesJan 7, 2013
Fact SheetFact sheet2 slides
Fact SheetFact sheet2 slides
Fact SheetFact sheet2 slides

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue534.5M465.3M399.2M330.4M274.3M206.5M230.8M201.6M174.7M155.1M
Cost of revenue133.7M117.8M98.9M84.4M68.5M57.2M60.5M54.5M48.6M44.0M
Gross profit400.8M347.5M300.4M245.9M205.9M149.3M170.3M147.1M126.2M111.1M
Research and development99.2M96.2M73.9M57.3M48.5M43.1M41.2M34.7M34.1M35.8M
Selling, general and administrative311.0M291.4M253.1M231.3M204.6M150.8M167.1M129.5M117.0M106.4M
Operating income-9.45M-40.0M-26.7M-42.7M55.2M-44.2M-33.1M-17.1M-25.0M-31.1M
Depreciation and amortization12.1M11.2M9.46M8.06M7.53M7.87M7.42M7.24M7.76M7.66M
EBITDA2.64M-28.8M-17.2M-34.6M62.7M-36.4M-25.7M-9.88M-17.2M-23.5M
Interest expense5.88M6.41M6.92M4.99M4.92M4.88M4.11M4.61M2.26M1.80M
Income before tax-10.2M-43.7M-29.8M-46.2M50.4M-48.0M-35.0M-20.9M-26.9M-33.3M
Income tax1.28M1.02M591.0K268.0K188.0K114.0K199.0K226.0K14.0K40.0K
Net income-11.4M-44.7M-30.4M-46.5M50.2M-48.2M-35.2M-21.1M-26.9M-33.3M
Earnings per share, basic-0.24-0.95-0.66-1.021.11-1.14-0.94-0.62-0.83-1.05
Earnings per share, diluted-0.24-0.95-0.66-1.021.09-1.14-0.94-0.62-0.83-1.05

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents167.4M122.7M84.3M58.1M43.7M41.9M28.5M32.2M21.8M24.2M
Short-term investments053.0M63.0M75.4M202.3M53.3M92.2M12.6M19.8M
Receivables66.7M60.3M52.5M42.7M33.0M23.1M28.0M25.2M23.1M21.1M
Inventory78.5M75.3M67.9M45.9M39.0M35.0M29.4M22.5M22.5M17.7M
Current assets322.5M267.8M266.2M215.2M196.1M306.7M143.2M174.7M82.3M85.7M
Property, plant and equipment42.6M31.4M28.3M32.6M27.1M28.7M30.0M
Goodwill234.8M234.8M234.8M234.8M234.8M234.8M234.8M105.3M105.3M105.3M
Total assets654.2M609.3M613.9M585.4M615.3M714.5M557.9M356.8M267.7M276.4M
Accounts payable25.3M25.0M27.4M19.9M18.6M12.7M14.9M9.66M12.4M10.7M
Current liabilities81.5M73.4M74.6M58.4M56.4M49.1M49.9M40.2M31.9M28.8M
Long-term debt61.9M61.9M60.6M56.8M59.7M53.4M59.6M35.6M24.1M23.9M
Total debt61.9M64.7M63.1M60.0M60.0M60.0M60.0M52.8M37.4M38.9M
Total liabilities162.2M148.4M147.8M128.7M131.6M302.1M310.5M107.4M106.5M108.0M
Shareholders' equity491.9M461.0M466.2M456.8M483.8M412.4M247.3M249.4M161.2M168.4M
Shares outstanding49.8M48.9M47.5M46.6M46.0M45.3M39.7M38.6M34.6M33.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations57.3M12.2M4.48M-22.1M-13.8M-19.9M-15.8M-4.17M-8.94M-15.1M
Capital spending-9.05M-11.5M-12.0M-16.9M-9.75M-5.26M-12.2M-6.21M-6.38M-7.69M
Free cash flow48.3M745.0K-7.51M-39.0M-23.5M-25.1M-28.0M-10.4M-15.3M-22.8M
Cash from investing-14.6M30.2M21.8M44.0M23.5M-156.2M-2.15M-85.4M3.76M-12.1M
Cash from financing1.18M-3.60M-32.0K-7.06M-7.64M189.4M14.4M100.2M2.76M27.7M
Dividends paid00-60.0K-6.04M-12.4M-14.2M-3.86M-25.8M-4.40M-28.3M
Share buybacks-11.2M-6.95M-6.56M-12.2M-18.0M-13.0M-9.03M-4.46M-2.01M-1.70M
Change in cash44.7M38.4M26.2M14.4M1.71M13.5M-3.75M10.4M-2.40M444.0K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
4 · Change in ownershipNov 10, 2026Insider tradeSEC
144 · Notice of proposed saleNov 6, 2026Other filingsSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
144 · Notice of proposed saleNov 4, 2026Other filingsSEC
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
8-K · Current reportNov 3, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 30, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 5, 2026Big-stake noticeSEC
4 · Change in ownershipSep 24, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleSep 23, 2026Other filingsSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
144 · Notice of proposed saleSep 11, 2026Other filingsSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
144 · Notice of proposed saleSep 8, 2026Other filingsSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
4 · Change in ownershipAug 26, 2026Insider tradeSEC
144 · Notice of proposed saleAug 24, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
4 · Change in ownershipAug 7, 2026Insider tradeSEC
4 · Change in ownershipAug 7, 2026Insider tradeSEC
144 · Notice of proposed saleAug 5, 2026Other filingsSEC
144 · Notice of proposed saleAug 5, 2026Other filingsSEC
4 · Change in ownershipAug 3, 2026Insider tradeSEC
4 · Change in ownershipJul 30, 2026Insider tradeSEC
4 · Change in ownershipJul 30, 2026Insider tradeSEC
4 · Change in ownershipJul 30, 2026Insider tradeSEC
144 · Notice of proposed saleJul 29, 2026Other filingsSEC
144 · Notice of proposed saleJul 28, 2026Other filingsSEC
144 · Notice of proposed saleJul 28, 2026Other filingsSEC
S-8 · Registration statement for employee plansJul 27, 2026Offer documentSEC
S-8 · Registration statement for employee plansJul 27, 2026Offer documentSEC
10-Q · Quarterly reportJul 27, 2026Quarterly reportSEC
8-K · Current reportJul 23, 2026ResultsSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
SD · Specialized disclosureMay 27, 2026ESG reportSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
144 · Notice of proposed saleMay 20, 2026Other filingsSEC
8-K · Current reportMay 19, 2026Management or board changeSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
144 · Notice of proposed saleMay 15, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K/A · Current report, amendedMay 5, 2026ResultsSEC
8-K · Current reportMay 5, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeApr 29, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeApr 28, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialApr 6, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 6, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
10-K · Annual reportFeb 19, 2026Annual reportSEC
8-K · Current reportFeb 17, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
8-K · Current reportJan 12, 2026ResultsSEC
4 · Change in ownershipJan 2, 2026Insider tradeSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
4 · Change in ownershipNov 26, 2025Insider tradeSEC
4 · Change in ownershipNov 26, 2025Insider tradeSEC
144 · Notice of proposed saleNov 26, 2025Other filingsSEC
144 · Notice of proposed saleNov 25, 2025Other filingsSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
144 · Notice of proposed saleNov 24, 2025Other filingsSEC
144 · Notice of proposed saleNov 21, 2025Other filingsSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2025Big-stake noticeSEC
10-Q · Quarterly reportOct 30, 2025Quarterly reportSEC
8-K/A · Current report, amendedOct 29, 2025ResultsSEC
8-K · Current reportOct 29, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 17, 2025Big-stake noticeSEC
4 · Change in ownershipSep 16, 2025Insider tradeSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
144 · Notice of proposed saleAug 22, 2025Other filingsSEC
4 · Change in ownershipAug 21, 2025Insider tradeSEC
144 · Notice of proposed saleAug 19, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeAug 12, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 12, 2025Big-stake noticeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 8, 2025Insider tradeSEC
4 · Change in ownershipAug 7, 2025Insider tradeSEC
144 · Notice of proposed saleAug 6, 2025Other filingsSEC
144 · Notice of proposed saleAug 5, 2025Other filingsSEC
S-8 · Registration statement for employee plansJul 30, 2025Offer documentSEC
10-Q · Quarterly reportJul 30, 2025Quarterly reportSEC
8-K · Current reportJul 29, 2025ResultsSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipMay 30, 2025Insider tradeSEC
SD · Specialized disclosureMay 29, 2025ESG reportSEC
144 · Notice of proposed saleMay 28, 2025Other filingsSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
8-K · Current reportMay 20, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeMay 14, 2025Big-stake noticeSEC
4 · Change in ownershipMay 7, 2025Insider tradeSEC
DEFA14A · Additional proxy materialMay 5, 2025Meeting noticeSEC
10-Q · Quarterly reportApr 30, 2025Quarterly reportSEC
8-K · Current reportApr 29, 2025ResultsSEC
DEFA14A · Additional proxy materialApr 7, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 7, 2025Meeting noticeSEC
8-K · Current reportMar 26, 2025Current reportSEC
4 · Change in ownershipMar 12, 2025Insider tradeSEC
4 · Change in ownershipMar 7, 2025Insider tradeSEC
144 · Notice of proposed saleMar 5, 2025Other filingsSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
S-3ASR · Registration statementFeb 14, 2025Offer documentSEC
10-K · Annual reportFeb 14, 2025Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
8-K · Current reportFeb 12, 2025ResultsSEC
8-K · Current reportJan 13, 2025ResultsSEC
4 · Change in ownershipDec 12, 2024Insider tradeSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 12, 2024Big-stake noticeSEC
10-Q · Quarterly reportOct 30, 2024Quarterly reportSEC
8-K · Current reportOct 29, 2024ResultsSEC
4 · Change in ownershipSep 18, 2024Insider tradeSEC
4 · Change in ownershipAug 19, 2024Insider tradeSEC
4 · Change in ownershipAug 16, 2024Insider tradeSEC
144 · Notice of proposed saleAug 15, 2024Other filingsSEC
S-8 · Registration statement for employee plansAug 1, 2024Offer documentSEC
10-Q · Quarterly reportJul 31, 2024Quarterly reportSEC
8-K · Current reportJul 30, 2024ResultsSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
SD · Specialized disclosureMay 31, 2024ESG reportSEC
4 · Change in ownershipMay 31, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
8-K · Current reportMay 14, 2024Management or board changeSEC
4 · Change in ownershipMay 3, 2024Insider tradeSEC
10-Q · Quarterly reportMay 2, 2024Quarterly reportSEC
144 · Notice of proposed saleMay 1, 2024Other filingsSEC
8-K · Current reportMay 1, 2024ResultsSEC
DEFA14A · Additional proxy materialApr 23, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialApr 23, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialApr 3, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 3, 2024Meeting noticeSEC
4 · Change in ownershipApr 3, 2024Insider tradeSEC
144 · Notice of proposed saleApr 1, 2024Other filingsSEC
PRE 14A · Preliminary proxy statementMar 20, 2024Meeting noticeSEC
4 · Change in ownershipMar 20, 2024Insider tradeSEC
144 · Notice of proposed saleMar 18, 2024Other filingsSEC
4 · Change in ownershipMar 18, 2024Insider tradeSEC
4 · Change in ownershipMar 14, 2024Insider tradeSEC
144 · Notice of proposed saleMar 12, 2024Other filingsSEC
4 · Change in ownershipMar 7, 2024Insider tradeSEC
4 · Change in ownershipMar 5, 2024Insider tradeSEC
4 · Change in ownershipMar 5, 2024Insider tradeSEC
4 · Change in ownershipMar 5, 2024Insider tradeSEC
4 · Change in ownershipMar 5, 2024Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from AtriCure, Inc.’s releases · as of Nov 2, 2026

Common shares
50,922,283
Fully diluted
50,922,283

Fully diluted

LineSharesAs of
Common shares50,922,283Nov 2, 2026

Share count over time

CountShares
Nov 2, 202650,922,283

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
BlackRock7.94MUS$446MSep 30, 2026
Vanguard6.27MUS$353MSep 30, 2026
Wellington4.12MUS$231MSep 30, 2026
AllianceBernstein2.93MUS$164MSep 30, 2026
Hood River Capital Management LLC2.84MUS$160MSep 30, 2026
State Street2.13MUS$120MSep 30, 2026
Nomura1.49MUS$83.5MSep 30, 2026
Geode Capital1.3MUS$73.2MSep 30, 2026
Goldman Sachs1.11MUS$62.3MSep 30, 2026
Dimensional1.02MUS$57.4MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Arrowstreet Capital, Limited Partnership940KUS$52.8MSep 30, 2026
Bank of America930KUS$52.3MSep 30, 2026
GW&K Investment Management, LLC905KUS$50.9MSep 30, 2026
BNP Paribas879KUS$49.4MSep 30, 2026
Neuberger Berman Group LLC850KUS$47.9MSep 30, 2026
Divisadero Street Capital Management, LP836KUS$47MSep 30, 2026
Kennedy Capital Management LLC698KUS$39.2MSep 30, 2026
First Light Asset Management, LLC662KUS$37.2MSep 30, 2026
Fidelity607KUS$34.1MSep 30, 2026
Citadel567KUS$31.9MSep 30, 2026
Northern Trust525KUS$29.5MSep 30, 2026
DAFNA Capital Management LLC523KUS$29.4MSep 30, 2026
Morgan Stanley493KUS$27.7MSep 30, 2026
AQR Capital Management LLC483KUS$27.1MSep 30, 2026
Champlain Investment Partners, LLC466KUS$26.2MSep 30, 2026
Sun Life462KUS$25.9MSep 30, 2026
Schwab457KUS$25.7MSep 30, 2026
Driehaus Capital Management LLC395KUS$22.2MSep 30, 2026
Panagora Asset Management Inc387KUS$21.7MSep 30, 2026
Principal386KUS$21.7MSep 30, 2026
Nuveen371KUS$20.8MSep 30, 2026
D. E. Shaw & Co., Inc.326KUS$18.3MSep 30, 2026
Sei Investments Co323KUS$18.2MSep 30, 2026
Wcm Investment Management, LLC323KUS$18.7MSep 30, 2026
Renaissance Technologies321KUS$18MSep 30, 2026
Loomis Sayles & Co L P314KUS$17.6MSep 30, 2026
First Eagle Investment Management, LLC289KUS$16.3MSep 30, 2026
UBS279KUS$15.7MSep 30, 2026
Osterweis Capital Management Inc279KUS$15.7MSep 30, 2026
Public Sector Pension Investment Board259KUS$14.8MSep 30, 2026
Invesco257KUS$14.5MSep 30, 2026
BNY256KUS$14.4MSep 30, 2026
Amundi236KUS$13.2MSep 30, 2026
Parkman Healthcare Partners LLC225KUS$12.7MSep 30, 2026
Topline Capital Management, LLC221KUS$12.4MSep 30, 2026
Raymond James Financial Inc221KUS$12.4MSep 30, 2026
Marshall Wace, LLP217KUS$12.2MSep 30, 2026
Nicholas Company, Inc.205KUS$11.5MSep 30, 2026
Susquehanna182KUS$10.2MSep 30, 2026
Universal- Beteiligungs- und Servicegesellschaft mbH174KUS$9.78MSep 30, 2026

This page holds 50 of 275 holders. Open Shareholders

Funds

HolderSharesValueAs of
Hood River Small-Cap Growth Fund1.53MUS$42.7MJun 30, 2026
Vanguard Total Stock Market Index Fund1.52MUS$42.5MJun 30, 2026
iShares Russell 2000 ETF1.3MUS$36.3MJun 30, 2026
Nomura Small Cap Core Fund1.22MUS$33.7MMay 29, 2026
Vanguard Small-Cap Index Fund1.1MUS$30.8MJun 30, 2026
AB Discovery Growth Fund, Inc.738KUS$20.6MJun 30, 2026
Vanguard Small-Cap Growth Index Fund633KUS$17.7MJun 30, 2026
Vanguard Extended Market Index Fund580KUS$16.2MJun 30, 2026
Fidelity Small Cap Index Fund545KUS$20.6MJul 31, 2026
Fidelity Enhanced Small Cap Core ETF461KUS$12.9MJun 30, 2026
Show 50 holders
HolderSharesValueAs of
iShares Russell 2000 Growth ETF461KUS$12.9MJun 30, 2026
Champlain Small Company Fund383KUS$10.7MJun 30, 2026
Osterweis Opportunity Fund354KUS$9.9MJun 30, 2026
MFS New Discovery Fund342KUS$9.46MMay 31, 2026
EQ/AB Small Cap Growth Portfolio305KUS$8.54MJun 30, 2026
Vanguard Strategic Equity Fund292KUS$8.16MJun 30, 2026
AB Small Cap Growth Portfolio281KUS$7.87MJun 30, 2026
Vanguard Explorer Fund278KUS$10.5MJul 31, 2026
First Eagle Small Cap Opportunity Fund263KUS$9.91MJul 31, 2026
Fidelity Extended Market Index Fund258KUS$7.14MMay 31, 2026
Vanguard Russell 2000 Index Fund249KUS$6.88MMay 31, 2026
Neuberger Intrinsic Value Fund244KUS$6.76MMay 31, 2026
SmallCap Growth Fund I239KUS$9.01MJul 31, 2026
Schwab U.S. Small-Cap ETF238KUS$6.58MMay 31, 2026
iShares U.S. Medical Devices ETF237KUS$6.64MJun 30, 2026
Nuveen Quant Small Cap Equity Fund228KUS$8.59MJul 31, 2026
Wasatch Ultra Growth Fund224KUS$6.26MJun 30, 2026
U.S. Small Cap Portfolio220KUS$8.31MJul 31, 2026
Grandeur Peak Global Opportunities Fund209KUS$7.89MJul 31, 2026
Nicholas Limited Edition, Inc.203KUS$7.66MJul 31, 2026
AMG GW&K Small Cap Core Fund201KUS$5.63MJun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund188KUS$5.27MJun 30, 2026
Vanguard Strategic Small-Cap Equity Fund187KUS$5.23MJun 30, 2026
Hood River New Opportunities Fund181KUS$5.08MJun 30, 2026
JNL Multi-Manager Small Cap Growth Fund179KUS$5MJun 30, 2026
U.S. Micro Cap Portfolio167KUS$6.32MJul 31, 2026
Vanguard Health Care Index Fund149KUS$4.13MMay 31, 2026
Dimensional U.S. Small Cap ETF126KUS$4.75MJul 31, 2026
MFS New Discovery Series123KUS$3.45MJun 30, 2026
Goldman Sachs Small Cap Equity Insights Fund122KUS$4.6MJul 31, 2026
Schwab Small-Cap Index Fund121KUS$4.58MJul 31, 2026
Dimensional U.S. Core Equity 2 ETF119KUS$4.49MJul 31, 2026
Small Cap Core Portfolio116KUS$3.24MJun 30, 2026
Small Cap Growth Stock Portfolio116KUS$3.24MJun 30, 2026
Advisors Capital Small/Mid Cap Fund105KUS$2.95MJun 30, 2026
Neuberger Small Cap Growth Fund93,441US$2.59MMay 31, 2026
Master Small Cap Index Series93,336US$2.61MJun 30, 2026
Fidelity Total Market Index Fund92,334US$2.55MMay 31, 2026
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF90,319US$2.53MJun 30, 2026
Hartford Small Cap Growth Hls Fund86,443US$2.42MJun 30, 2026

This page holds 50 of 250 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Johnson B Kristine
Director
Sale2,452USD 58.48US$143KNov 6, 2026
Privitera Salvatore
Officer: Chief Technical Officer
Sale8,404USD 65.00US$546KNov 4, 2026
Privitera Salvatore
Officer: Chief Technical Officer
Sale4,519USD 60.00US$271KSep 23, 2026
Groves Regina E
Director
Sale5,313USD 54.22US$288KSep 11, 2026
Privitera Salvatore
Officer: Chief Technical Officer
Sale3,657USD 55.00US$201KSep 8, 2026
Privitera Salvatore
Officer: Chief Technical Officer
Sale7,763USD 52.50US$408KSep 2, 2026
Dahlquist Karl S.
Officer: Chief Legal Officer
Sale9,370USD 48.89US$458KAug 24, 2026
Prange Karen
Director
Sale3,564USD 38.80US$138KAug 5, 2026
Yuen Maggie
Director
Sale3,500USD 38.42US$134KAug 5, 2026
Noznesky Justin J
Officer: Chief Mktg & Strategy Officer
Sale6,182USD 38.80US$240KJul 29, 2026
All 14 trades
TradeTradeSharesPriceValueDate
Wehrwein Sven
Director
Sale25,000USD 37.84US$946KJul 28, 2026
Doraiswamy Vinayak
Officer: Chief Scientific Officer
Sale6,000USD 38.88US$233KJul 28, 2026
Prange Karen
Director
Sale3,000USD 28.65US$85,950May 20, 2026
Doraiswamy Vinayak
Officer: Chief Scientific Officer
Sale5,000USD 28.13US$141KMay 15, 2026

Big stakes

StakeStakeSharesDateFiling
BlackRock, Inc.15.40%7.84MSep 30, 2026Schedule 13G
Wellington Management Group LLP8.10%4.12MSep 30, 2026Schedule 13G
Vanguard Portfolio Management LLC7.22%3.68MSep 30, 2026Schedule 13G
Hood River Capital Management LLC6.23%3.1MDec 31, 2025Schedule 13G
AllianceBernstein L.P.5.50%2.77MJun 30, 2026Schedule 13G
Vanguard Capital Management LLC5.08%2.53MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Sven A. Wehrwein
Other companies: Proto Labs, Inc. (Director · Since at least Feb 23, 2012); Cogentix Medical Inc (Director · Mar 31, 2015 – Jul 31, 2015 · Past); SPS Commerce, Inc. (Director · Apr 21, 2010 – May 13, 2025 · Past); Compellent Technologies Inc (Director · Oct 9, 2007 – Feb 22, 2011 · Past); Synovis Life Technologies Inc (Director · Nov 1, 2006 – Oct 26, 2011 · Past); Autoscope Technologies Corporation (Director · Oct 1, 2006 – May 25, 2011 · Past); Uroplasty Inc (Director · Sep 1, 2006 – Mar 31, 2015 · Past); Vital Images Inc (Director · Mar 14, 2006 – Jun 15, 2011 · Past)
Director · Since at least Nov 11, 2016
Karen N. Prange
Other companies: Outset Medical, Inc. (Director · Since at least Jan 9, 2026); Embecta Corp. (Director · Since at least Apr 1, 2022); Nevro Corp (Director · Dec 17, 2019 – Apr 3, 2025 · Past); Cantel Medical Corp (Director · Oct 28, 2019 – Jun 2, 2021 · Past); Henry Schein, Inc. (EVP&CEO Gl.AH.Med.Den.Sur.Grp · May 17, 2016 – Mar 2, 2018 · Past)
Director · Since at least Dec 4, 2019
B. Kristine Johnson
Other companies: ClearPoint Neuro Inc. (Director · Since at least Sep 1, 2019); Paragon 28 Inc (Director · Dec 1, 2021 – Apr 21, 2025 · Past); The Spectranetics Corp (Director · May 31, 2012 – Aug 9, 2017 · Past); Piper Sandler Companies (Director · May 5, 2010 – Dec 13, 2019 · Past)
Director · Since at least Mar 21, 2017
Scott William Drake
Other companies: Paragon 28 Inc (Director · Oct 14, 2021 – May 18, 2022 · Past); Zayo Group Holdings Inc (Director · Nov 6, 2018 – Mar 9, 2020 · Past); The Spectranetics Corp (President, CEO, Director · Mar 5, 2012 – Aug 9, 2017 · Past)
Director · Sep 3, 2013 – May 7, 2021 · Past
Daniel P. Florin
Other companies: Pulmonx Corporation (Board Member · Since at least Sep 30, 2020); Zimmer Biomet Holdings, Inc. (Exec. VP, CFO · Jun 29, 2015 – May 8, 2019 · Past)
Director · Dec 4, 2019 – May 20, 2021 · Past
Deborah H. Telman
Other companies: Gilead Sciences, Inc. (EVP, Corporate Affairs & GC · Since at least Aug 1, 2022); Organon & Co. (EVP GC & Corporate Secretary · Jun 2, 2021 – May 4, 2022 · Past)
Director · Since at least Jun 15, 2021
Thomas J Etergino
Other companies: 1stdibs.com, Inc. (Chief Financial Officer · Since at least Mar 28, 2022); TheStreet Inc (Chief Financial Officer · Sep 7, 2010 – Sep 7, 2012 · Past)
Vice President and CFO · Jun 21, 2006 – Jun 21, 2006 · Past
Gene R McGrevin
Other companies: Microtek Medical Holdings Inc (Director · May 1, 2006 – Nov 9, 2007 · Past)
Director · Apr 6, 2006 – Apr 6, 2006 · Past
Maggie S. Yuen
Other companies: Penumbra, Inc. (Chief Financial Officer · Since at least Nov 4, 2026)
Director · Since at least Aug 7, 2026
Maggie Yuen
Other companies: Penumbra, Inc. (Chief Financial Officer · Since at least May 2, 2025)
Director · Since at least May 19, 2025
All 35 people
PersonSeat
Mark A Collar
Other companies: First Financial Bancorp. (Director · Feb 3, 2009 – May 23, 2016 · Past)
Director · Nov 6, 2008 – Mar 13, 2023 · Past
Michael H. Carrel
Other companies: Inspire Medical Systems, Inc. (Director · Since at least Jul 20, 2026)
President, Chief Executive Officer and Director · Since at least Jun 30, 2025
Patricia J Kennedy
Other companies: Biotricity, Inc. (Director · Jul 16, 2019 – Apr 7, 2020 · Past)
VP and GM, International · Oct 1, 2011 – Oct 27, 2015 · Past
Regina E. Groves
Other companies: Fulgent Genetics, Inc. (Director · Since at least Jan 3, 2023)
Director · Since at least Mar 21, 2017
Stewart W Strong
Other companies: Haemonetics Corporation (President, Global Hospital · Aug 6, 2021 – Jul 26, 2024 · Past)
VP Global Marketing · Dec 5, 2007 – Feb 9, 2012 · Past
Andrew L LuxSVP, Ops & Quality · Jan 16, 2012 – Jun 30, 2017 · Past
Angela L. WirickChief Financial Officer · Since at least Aug 6, 2020
Deborah Lee YountChief Human Resources Officer · Jun 1, 2022 – Mar 1, 2025 · Past
Deborah L MorleyVP Clinical Affairs · May 28, 2008 – Jul 29, 2009 · Past
Donald C HarrisonDirector · May 15, 2012 – May 23, 2013 · Past
Douglas J. SeithChief Operating Officer · Since at least Jan 14, 2013
Elizabeth D KrellDirector · Jun 21, 2006 – May 7, 2018 · Past
Elsa Chi AbruzzoVP Regulatory&Clinical Affairs · Jun 20, 2007 – Jun 20, 2007 · Past
Julie A PitonVP Fin & Admin & CFO · Jan 23, 2007 – Feb 17, 2012 · Past
Justin NozneskyChief Marketing and Strategy Officer · Since at least Feb 3, 2016
Karl DahlquistChief Legal Officer · Since at least May 20, 2021
Lee R WrubelDirector · Aug 5, 2005 – May 19, 2008 · Past
Mark R LanningDirector · Mar 29, 2019 – May 5, 2021 · Past
Norman R WeldonDirector · Aug 5, 2005 – Aug 5, 2005 · Past
Robert S. WhiteDirector · Since at least May 20, 2021
Salvatore PriviteraChief Technical Officer · Since at least Jun 14, 2010
Shlomi NachmanDirector · Since at least Nov 5, 2026
Shlomo NachmanDirector · Since at least Jan 4, 2024
Tonya AustinChief Human Resources Officer · May 20, 2021 – May 13, 2022 · Past
Vinayak DoraiswamyChief Scientific Officer · Since at least May 28, 2025

Open People

Log in to ask 6ix AI your own questions about AtriCure, Inc.